ScinoPharm Taiwan Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ScinoPharm Taiwan Ltd

Watchlist Manager

Watchlist

Price: 18.65 TWD 0.81% Market Closed

Market Cap: NT$14.7B

	ScinoPharm Taiwan Ltd TWSE:1789	TW
	International Consolidated Airlines Group SA LSE:IAG	UK
	Intel Corp SIX:INTC	US
O	ONWARD Medical NV F:63E	NL
V	Vistry Group PLC OTC:BVHMF	UK
	Eurasia Mining PLC LSE:EUA	UK
A	Agios Pharmaceuticals Inc SWB:8AP	US
	Provident Investasi Bersama Tbk PT IDX:PALM	ID
	Brixmor Property Group Inc NYSE:BRX	US
A	Aspeed Technology Inc TPEX:5274	TW
	Nifco Inc TSE:7988	JP
M	Materialise NV SWB:06MA	BE
T	Texas Instruments Inc DUS:TII	US
A	Amphenol Corp F:XPH	US
	Gruppa Cherkizovo PAO MOEX:GCHE	RU
C	Century Aluminum Co F:EY3	US
	Warehouses de Pauw NV F:WPHB	BE
	DIAMOND FOOD INDONESIA Tbk PT IDX:DMND	ID
	Delivery Hero SE F:DHER	DE

Profitability Summary

ScinoPharm Taiwan Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

30%

Sustainable 3Y Average Gross Margin

37%

Declining Gross Margin

37% > 30%

Negative Operating Margin

-2%

Low 3Y Average Operating Margin

Declining Operating Margin

8% > -2%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

8% > 1%

Exceptional Free Cash Flow Margin

19%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.